Bridge to Affective Wellness

Bridge to Affective Wellness in Concord, North Carolina offers Spravato (esketamine) for adults with treatment-resistant depression and other complex mood disorders that have not responded to two or more antidepressant trials or caused intolerable side effects. Spravato, which received FDA approval for treatment-resistant depression in 2019, works differently from medications that focus on serotonin and norepinephrine.

Patients self-administer the nasal spray into both nostrils while under physician supervision, remaining in the office for 120 minutes of monitoring afterward, with a ride home required.

Founded by Dr. Nathan Carter, the practice specializes in complicated and treatment-resistant mood disorders that may require new or unconventional approaches. Bridge to Affective Wellness operates alongside Bridge to Integrated Living, which provides substance abuse psychiatry services.